#Vacciné

whippletom

whippletom

Demographics of the South African study into Oxford vaccine Criteria for mild or moderate cases Neutralization data - immune responses "similar if not better" Efficacy, pre November. South African scientists

Business Insider

businessinsider

The largest vaccination campaign in the history of the US has begun. The first person to be publicly vaccinated against the #coronavirus in the US was an ICU nurse from

Emily Burns😊 #SmilesMatter DM’s OK

Emily_Burns_V

1/nMeet Jo. Jo is a 20-something MPH who works for the CDC. Jo’s model is being used to decide who gets vaccinated in the U.S. Jo is a proud American

Tim Mak

timkmak

MIT study: Moderna, Pfizer, AstraZeneca and other vaccines may not do as well covering people of Black or Asian genetic ancestry as they do for white peoplehttps://www.zdnet.com/article/mit-machine-learning-models-find-gaps-in-coverage-by-m

Ryan Wain

ryan_wain

We're in lockdown until those at risk are vaccinated. Administering a first dose to 30 million has to become a single-minded national mission. The Govt may have ambition but lack

Pieter Cleppe

pietercleppe

"If the European Commission's covid-jab-purchase agreement with CureVac is anything to go by, EUHQ may not have much of a legal leg to stand on with its gripes over #AstraZeneca's

David Grainger

sciencescanner

Lots of people highlighting pessimistic estimates of duration of protection for #COVID vaccines - but the facts guides us in the opposite direction: Im optimistic for multi-year duration of protectionWhy?1/n

Benjy Renton

bhrenton

New: 23 states (46% of all states) have been told from the federal government to expect fewer doses of the Pfizer vaccine next week, some shipments cut by as much

Prof. Akiko Iwasaki

VirusesImmunity

How well do various vaccines reduce severe COVID disease & death? Awesome @YaleMed students, @dariusdariusdar, @ChaneyKalinich, @Larson_HaleighT & Caroline Valdez put together summary tables from vaccine trials. Remarkable ability o

BK Titanji #ILookLikeAScientist

Boghuma

Preprint-ChAdOx1 trial in HIV(-) people in South Africa. 23/717 (3.2%) placebo & 19/750 (2.5%) vaccine recipients developed mild-moderate # COVID19. Of the cases, 39/42 (92.9%) were the B.1.351 variant –

Benjy Renton

bhrenton

Most vaccine trackers by media outlets have been focusing on one metric: what percentage of the population has been vaccinated. However, the single-most important metric for us to currently watch

Andrew Flood 👨🏻‍💻📝🕺

andrewflood

Covid-19 vaccine candidate is 90% effective, says manufacturer - mass roll out will take a while but if 90% holds this certainly makes a huge differencehttps://www.theguardian.com/world/2020/nov/09/covid-19-vaccine-candidate-effective-pfize

Alexis C. Dennis, MPH

_ACDennis

Hello I am one of them. While vaccine hesitancy exists, it doesn’t fully explain the emergent racial/ethnic and SES disparities we’re seeing in vaccination uptake across the US. Fundamental

𝐒𝐚𝐜𝐜𝐡𝐚𝐧

sacchanxd

I'm gonna start a thread on updates and like-- my experience(?) with the vaccine since some friends asked for itAnd I figured if anyone felf iffy about getting vaccinated this

Max Roser

MaxCRoser

What is going on with the vaccination campaigns?Pfizer/Biontech said that they’d provide 50 million doses worldwide within 2020.There are other vaccines too.Now, one day before the end of 2020, we

Adam John Ritchie

adamjohnritchie

I was involved in getting the #oxfordvaccine @JennerInstitute manufacturing process and consortium up and running. Here is a thread of why there is an issue with doses, with some science

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.